BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34406854)

  • 1. A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus.
    Beattie SR; Krysan DJ
    mSphere; 2021 Aug; 6(4):e0053921. PubMed ID: 34406854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dual-Readout High-Throughput Screening Assay for Small Molecules Active Against Aspergillus Fumigatus.
    Beattie SR; Krysan DJ
    Methods Mol Biol; 2023; 2658():35-42. PubMed ID: 37024693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.
    Dos Reis TF; Horta MAC; Colabardini AC; Fernandes CM; Silva LP; Bastos RW; Fonseca MVL; Wang F; Martins C; Rodrigues ML; Silva Pereira C; Del Poeta M; Wong KH; Goldman GH
    mBio; 2021 Aug; 12(4):e0145821. PubMed ID: 34372704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fluorescence-Based High-Throughput Screening Assay to Identify Growth Inhibitors of the Pathogenic Fungus Aspergillus fumigatus.
    Smith TM; Richie DL; Tao J
    Methods Mol Biol; 2016; 1439():171-9. PubMed ID: 27316995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Wall Composition Heterogeneity between Single Cells in Aspergillus fumigatus Leads to Heterogeneous Behavior during Antifungal Treatment and Phagocytosis.
    Bleichrodt RJ; Foster P; Howell G; Latgé JP; Read ND
    mBio; 2020 May; 11(3):. PubMed ID: 32398317
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening method to identify inhibitors of siderophore biosynthesis in the opportunistic fungal pathogen, Aspergillus fumigatus.
    Pinto LJ; Moore MM
    Lett Appl Microbiol; 2009 Jul; 49(1):8-13. PubMed ID: 19453952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of conidiophore development in Aspergillus fumigatus by an Escherichia coli DH5α strain, a promising antifungal candidate against aspergillosis.
    Balhara M; Ruhil S; Kumar M; Dhankhar S; Chhillar AK
    J Mycol Med; 2014 Mar; 24(1):1-12. PubMed ID: 23978655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of pyrimidine-based antifungals with anti-mold activity disrupt ER function in
    Kelty MT; Miron-Ocampo A; Beattie SR
    Microbiol Spectr; 2024 Jun; ():e0104524. PubMed ID: 38916314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Aspergillus fumigatus Phosphoproteome Reveals Roles of High-Osmolarity Glycerol Mitogen-Activated Protein Kinases in Promoting Cell Wall Damage and Caspofungin Tolerance.
    Mattos EC; Silva LP; Valero C; de Castro PA; Dos Reis TF; Ribeiro LFC; Marten MR; Silva-Rocha R; Westmann C; da Silva CHTP; Taft CA; Al-Furaiji N; Bromley M; Mortensen UH; Benz JP; Brown NA; Goldman GH
    mBio; 2020 Feb; 11(1):. PubMed ID: 32019798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus.
    du Pré S; Beckmann N; Almeida MC; Sibley GEM; Law D; Brand AC; Birch M; Read ND; Oliver JD
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to drug discovery: high-throughput screening of microbial natural extracts against Aspergillus fumigatus using resazurin.
    Monteiro MC; de la Cruz M; Cantizani J; Moreno C; Tormo JR; Mellado E; De Lucas JR; Asensio F; Valiante V; Brakhage AA; Latgé JP; Genilloud O; Vicente F
    J Biomol Screen; 2012 Apr; 17(4):542-9. PubMed ID: 22233645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
    Wetter TJ; Hazen KC; Cutler JE
    Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
    Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luciferase-Based High-Throughput Screen with Aspergillus fumigatus to Identify Antifungal Small Molecules.
    Opperman TJ; Dhingra S; Gutierrez-Perez C; Kwasny SM; Cramer RA
    Methods Mol Biol; 2023; 2658():17-34. PubMed ID: 37024692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Neutrophils Produce Antifungal Extracellular Vesicles against Aspergillus fumigatus.
    Shopova IA; Belyaev I; Dasari P; Jahreis S; Stroe MC; Cseresnyés Z; Zimmermann AK; Medyukhina A; Svensson CM; Krüger T; Szeifert V; Nietzsche S; Conrad T; Blango MG; Kniemeyer O; von Lilienfeld-Toal M; Zipfel PF; Ligeti E; Figge MT; Brakhage AA
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Aspergillus fumigatus Virulence through Targeted Dysregulation of the Conidiation Pathway.
    Stewart JIP; Fava VM; Kerkaert JD; Subramanian AS; Gravelat FN; Lehoux M; Howell PL; Cramer RA; Sheppard DC
    mBio; 2020 Feb; 11(1):. PubMed ID: 32019801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases in the Prevention of Experimental Invasive Aspergillosis.
    Ostapska H; Raju D; Lehoux M; Lacdao I; Gilbert S; Sivarajah P; Bamford NC; Baker P; Nguyen TTM; Zacharias CA; Gravelat FN; Howell PL; Sheppard DC
    mBio; 2021 Oct; 12(5):e0244621. PubMed ID: 34579578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a critical step in fungal hexosamine biosynthesis.
    Lockhart DEA; Stanley M; Raimi OG; Robinson DA; Boldovjakova D; Squair DR; Ferenbach AT; Fang W; van Aalten DMF
    J Biol Chem; 2020 Jun; 295(26):8678-8691. PubMed ID: 32341126
    [No Abstract]   [Full Text] [Related]  

  • 20. Human Vγ9Vδ2 T cells exhibit antifungal activity against
    Koga S; Takazono T; Namie H; Okuno D; Ito Y; Nakada N; Hirayama T; Takeda K; Ide S; Iwanaga N; Tashiro M; Sakamoto N; Watanabe A; Izumikawa K; Yanagihara K; Tanaka Y; Mukae H
    Microbiol Spectr; 2024 Apr; 12(4):e0361423. PubMed ID: 38426765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.